Custom Antibody Market Size 2025-2029
The custom antibody market size is forecast to increase by USD 305.2 million, at a CAGR of 9.3% between 2024 and 2029.
Sustained investment in biopharmaceutical research and the pursuit of personalized medicine are major drivers for the global custom antibody market. This demand is met by a decisive shift toward recombinant antibody production, a trend that offers superior consistency and engineering potential over traditional methods. The use of in vitro gene cloning and recombinant antibody technologies addresses the critical issue of reagent variability, which has historically been a significant concern in the immunology market. These advancements are essential for developing next-generation therapeutics and advanced diagnostic platforms, where tools like enzyme-linked immunosorbent assay (ELISA) market products are frequently employed, while also enabling precise antibody affinity maturation.The market is also shaped by the high costs and extended timelines inherent in custom antibody development, which can be prohibitive for entities with limited budgets. The process is resource-intensive, requiring substantial investment in specialized equipment and scientific expertise, with no guarantee of a successful outcome for every antigen. This operational challenge affects project timelines in areas such as autoimmune disease diagnostics and the development of bispecific antibodies for cancer. Balancing the need for efficiency with the biological complexities of generating high-affinity antibodies remains a central issue for service providers in the immunodiagnostics market.
What will be the Size of the Custom Antibody Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The evolution of the global custom antibody market is characterized by a continuous interplay between research demands and technological innovation. The need for high-affinity antibodies and highly specific reagents drives the adoption of advanced techniques such as single b-cell screening and recombinant antibody production. These methods are becoming essential for applications in the immunodiagnostics market, where precision is paramount. The development of custom immunoreagents for studying novel biological pathways illustrates the market's role in advancing fundamental science.A persistent focus on enhancing the functional properties of antibodies and ensuring batch-to-batch consistency shapes service offerings. Techniques like in vitro affinity maturation and sophisticated antigen design are increasingly standard. These processes are critical for developing reagents for complex applications, including autoimmune disease diagnostics and research into bispecific antibodies for cancer. The market's trajectory is closely tied to the progress in therapeutic discovery and the need for reliable tools to support it.
How is this Custom Antibody Industry segmented?
The custom antibody industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Type
- Monoclonal antibodies
- Polyclonal antibodies
- Recombinant antibodies
- Others
- Source
- Application
- Geography
- North America
- Europe
- Germany
- UK
- France
- The Netherlands
- Italy
- Spain
- Russia
- Asia
- Rest of World (ROW)
By Type Insights
The monoclonal antibodies segment is estimated to witness significant growth during the forecast period.
Monoclonal antibodies are a cornerstone of the market, prized for their exceptional specificity and batch-to-batch consistency. Derived from a single B-cell clone, each antibody binds to a specific epitope, making them ideal for therapeutic development and high-precision diagnostic assays where reproducibility is critical. The development of these antibodies for the cancer monoclonal antibodies market involves advanced techniques to ensure high-affinity binding and minimal off-target effects. Monoclonal antibodies represented over 47% of the market in the previous fiscal year.
The traditional method for producing monoclonal antibodies is hybridoma technology, although this process is often time-consuming. These reagents are essential for validating novel drug targets, elucidating biological pathways, and serving as reference standards in both academic and biopharmaceutical research. The high degree of specificity justifies the investment for applications that demand the utmost precision and reliability, particularly in developing tools for autoimmune disease diagnostics and other clinical areas requiring validated reagents.
Request Free Sample
The Monoclonal antibodies segment was valued at USD 178.80 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 36.2% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
North America stands as the largest and most mature region in the global custom antibody market. This dominance is driven by a powerful combination of the world's most extensive pharmaceutical and biotechnology industry, substantial government funding for biomedical research, and a vibrant ecosystem of academic and private research centers. The high concentration of major drug developers in North America creates constant and high-volume demand for custom antibodies for therapeutic discovery and diagnostic development. In 2023, the region accounted for approximately 42.2% of the global market.
Furthermore, research institutions in North America are at the forefront of adopting advanced techniques that require highly specific and validated reagents, including those for the immunology market. The region is home to numerous leading service providers, fostering a competitive landscape characterized by technological innovation. The stringent regulatory environment also drives demand for well-characterized antibodies, especially for clinical applications. A strong venture capital landscape ensures a sustained pipeline of demand from new life sciences ventures, supporting their discovery programs.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global custom antibody market is experiencing robust growth, driven by advancements in antibody development for drug discovery. Pharmaceutical and biotech firms are heavily investing in this sector for critical processes such as target validation and mechanism of action, paving the way for innovations like custom antibody for personalized medicine. The sophisticated practice of antibody engineering for therapeutic use is leading to novel treatments, including the generation of bispecific antibodies which requires precise heavy and light chain pairing. Moreover, the burgeoning field of custom antibodies for cell therapy is expanding therapeutic possibilities. Before clinical application, rigorous preclinical safety assessments with antibodies are essential to evaluate the functional properties of antibodies. This entire pipeline is supported by cutting-edge recombinant antibody production platforms and advanced antigen design strategies.Breakthroughs in discovery methods, including single b-cell screening technologies and the in vitro affinity maturation process, are accelerating the creation of highly specific antibodies. This progress is particularly impactful in diagnostics, where custom antibody fragments for diagnostics are enabling more sensitive diagnostic assays for patient biomarkers. The development of anti-idiotypic antibodies is also crucial for pharmacokinetic studies and as reagents for clinical trial assays. For both therapeutic and research applications, the demand for custom immunoreagents for research and high-performance validated reagents is at an all-time high. Key industry players and OEM suppliers are focused on ensuring stringent batch-to-batch consistency in antibodies to guarantee reliability and reproducibility across all applications.
What are the key market drivers leading to the rise in the adoption of Custom Antibody Industry?
- Increasing research and development investments in biopharmaceuticals and personalized medicine are a key driver for the market.
Increasing investments in biopharmaceutical research and development (R&D) are a primary driver for the custom antibody market. As therapeutic pipelines increasingly focus on biologics such as antibody-drug conjugates, the demand for highly specific and well-characterized antibodies for target validation and preclinical assessments becomes critical. Custom antibody services provide the tailored tools necessary to investigate novel biological pathways. Moreover, the paradigm of personalized medicine, which relies on identifying specific patient biomarkers, escalates the need for antibodies designed against unique antigens. This demand extends beyond oncology to immunology and neurology, where targeted therapies offer significant advantages and where North America holds a commanding share of the market opportunity at over 36.24%.Technological advancements in antibody engineering and production platforms significantly influence market dynamics. The industry is moving beyond traditional hybridoma technology toward more efficient methods like recombinant antibody technologies, including phage display and yeast display. These innovations enable the in vitro selection of antibodies with precisely defined characteristics such as high affinity and stability, shortening development timelines and addressing ethical concerns by eliminating animal immunization. The development of single b-cell screening technologies represents another leap forward, allowing for the rapid isolation of high-affinity monoclonal antibodies directly from the host's immune repertoire, preserving the natural heavy and light chain pairing for superior functional properties.
What are the market trends shaping the Custom Antibody Industry?
- The rise of recombinant and engineered antibodies is an important upcoming trend in the market.
A dominant trend shaping the market is the shift from traditional hybridoma-based monoclonal antibodies to fully recombinant production methods. Recombinant antibodies, generated using in vitro gene cloning technologies, offer superior batch-to-batch reproducibility, addressing the critical issue of reagent variability in the immunology market. This trend is also driven by the demand for more sophisticated antibody formats beyond standard immunoglobulin G. Recombinant technology enables the straightforward engineering of antibody fragments and complex formats like bispecific antibodies for cancer, which are increasingly sought after for next-generation therapeutics and advanced diagnostic platforms. Europe accounts for a significant portion of this market's opportunity, representing 28.67% of the landscape.The integration of artificial intelligence (AI) and machine learning is a transformative trend within the custom antibody market. These computational tools are applied across the antibody discovery and development workflow to increase speed and improve success rates. AI algorithms can analyze vast datasets of protein sequences to predict antigen immunogenicity, identify optimal epitope targets, and design antibody variable regions de novo. This in silico approach helps de-risk the development process by prioritizing candidates with the highest probability of success before laboratory work begins. Machine learning models can also optimize development protocols, such as immunization strategies and cell culture conditions, to maximize antibody yield and quality.
What challenges does the Custom Antibody Industry face during its growth?
- The high costs and long timelines associated with custom antibody development are a key challenge affecting industry growth.
A significant challenge facing the custom antibody market is the high cost and extended timeframe required for development. The process is resource-intensive, involving complex stages from antigen design and synthesis to host immunization, screening, and antibody production. For monoclonal antibody development using traditional hybridoma technology, the process can take six to eight months or longer, with no guarantee of success. These high costs can be prohibitive for smaller academic labs and early-stage biotech startups, thereby constraining market access. The long lead times also pose challenges for research projects on tight deadlines, potentially slowing the pace of drug discovery and diagnostic development. Asia's market opportunity stands at 27.59%.The commercialization pathway for products incorporating custom antibodies is governed by stringent and evolving regulatory frameworks, presenting a major challenge. Regulatory bodies have rigorous requirements for the characterization, validation, and manufacturing of antibody reagents used in clinical applications. For diagnostic antibodies, comprehensive analytical and clinical validation is necessary to prove the assay's accuracy and utility. For instance, the transition to the european union's in vitro diagnostic regulation (IVDR) imposes stricter requirements on diagnostic manufacturers, placing a greater burden on reagent providers to supply exhaustive validation data and demonstrate robust manufacturing consistency. This regulatory landscape requires significant investment in quality management systems and regulatory expertise.
Exclusive Customer Landscape
The custom antibody market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the custom antibody market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, custom antibody market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abcam plc - The company provides custom antibody services, encompassing the development and production of monoclonal, polyclonal, and recombinant antibodies. These services cater to a wide range of applications across academic, commercial, and industrial research sectors. The offerings are designed to support various stages of discovery and development, from basic research and signaling pathway analysis to diagnostic assay creation and therapeutic candidate generation. Solutions are available for diverse and challenging targets, with options for different host species and large-scale production capabilities to meet client-specific requirements in immunology, oncology, and other biomedical fields.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abcam plc
- Abmart
- Agilent Technologies Inc.
- Bio Rad Laboratories Inc.
- BioLegend Inc.
- Cell Signaling Technology Inc.
- Creative Diagnostics
- GenScript Biotech Corp.
- Kaneka Eurogentec SA
- Laboratory Corp.
- LifeSpan BioSciences Inc.
- Merck KGaA
- ProMab Biotechnologies, Inc
- Proteo Genix
- RayBiotech Life Inc.
- Rockland Immunochemicals Inc.
- Thermo Fisher Scientific Inc.
- YenZym Antibodies, LLC
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Custom Antibody Market
In February 2024, Genmab A/S announced plans to construct a new, state-of-the-art research and development center in the Netherlands, aimed at expanding its capabilities in antibody research and development.In May 2024, GenScript Biotech Corp. opened a new automated production facility in Singapore, designed to increase its manufacturing capacity for proteins and custom antibodies to serve clients in the APAC region and globally.In April 2024, Thermo Fisher Scientific Inc. highlighted its expanded collaborations with AI and data analytics firms to enhance its biologic drug discovery services, including the in silico design and optimization of antibody candidates.
Research Analyst Overview
The global custom antibody market is characterized by a dynamic interplay of established and advancing technologies. Core operations revolve around custom antibody services, including both polyclonal antibody services and monoclonal antibody production through techniques like hybridoma development services. The sector is continuously adapting, incorporating sophisticated methods such as recombinant antibody engineering, phage display technology, and single b-cell cloning to enhance specificity and functionality. Foundational processes like antigen design and synthesis and diverse host species immunization protocols are evolving to meet complex research demands. The refinement of antibody characterization and epitope mapping services further illustrates this evolution, supporting the development of highly targeted reagents for intricate biological studies. Industry models suggest an expansion of around 12% in the near term, reflecting sustained demand for these specialized services.The application landscape is expanding as advancements in therapeutic antibody discovery and diagnostic antibody development continue. This progression requires a sophisticated ecosystem of support services, from antibody library construction using yeast display systems to stable cell line generation for consistent production. The creation of specialized formats, including bispecific antibody formats, single-domain antibodies, and nanobody development, is becoming more common. Further processing steps like antibody purification services, antibody fragmentation services, and antibody conjugation services are integral to preparing reagents for specific uses. The development of chimeric antibody generation and humanized antibody services is critical for therapeutic pipelines, while immunogenicity testing and pharmacokinetic assays ensure clinical viability. These advancements supply essential materials like flow cytometry antibodies and antibody drug conjugate reagents.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Custom Antibody Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
299
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 9.3%
|
|
Market growth 2024-2029
|
USD 305.2 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
9.2%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, The Netherlands, Italy, Spain, Russia, China, Japan, India, South Korea, Indonesia, Thailand, Singapore, Australia, Brazil, South Africa, UAE, Saudi Arabia, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Custom Antibody Market Research and Growth Report?
- CAGR of the Custom Antibody industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the custom antibody market growth of industry companies
We can help! Our analysts can customize this custom antibody market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Custom Antibody Market 2019 - 2023
- Historic Market Size - Data Table on Global Custom Antibody Market 2019 - 2023 ($ billion)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- 5.3 Source segment analysis 2019 - 2023
- Historic Market Size - Source Segment 2019 - 2023 ($ billion)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 Impact of AI in the Global Custom Antibody Market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Monoclonal antibodies - Market size and forecast 2024-2029
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- 8.4 Polyclonal antibodies - Market size and forecast 2024-2029
- Chart on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Polyclonal antibodies - Year-over-year growth 2024-2029 (%)
- 8.5 Recombinant antibodies - Market size and forecast 2024-2029
- Chart on Recombinant antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Recombinant antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Recombinant antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Recombinant antibodies - Year-over-year growth 2024-2029 (%)
- 8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by Source
- 9 Market Segmentation by Source
- 9.1 Market segments
- Chart on Source - Market share 2024-2029 (%)
- Data Table on Source - Market share 2024-2029 (%)
- 9.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
- 9.3 Rabbit - Market size and forecast 2024-2029
- Chart on Rabbit - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rabbit - Market size and forecast 2024-2029 ($ billion)
- Chart on Rabbit - Year-over-year growth 2024-2029 (%)
- Data Table on Rabbit - Year-over-year growth 2024-2029 (%)
- 9.4 Mice - Market size and forecast 2024-2029
- Chart on Mice - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mice - Market size and forecast 2024-2029 ($ billion)
- Chart on Mice - Year-over-year growth 2024-2029 (%)
- Data Table on Mice - Year-over-year growth 2024-2029 (%)
- 9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Source
- Market opportunity by Source ($ billion)
- Data Table on Market opportunity by Source ($ billion)
10 Market Segmentation by Application
- 10 Market Segmentation by Application
- 10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 10.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 10.4 Infectious disease - Market size and forecast 2024-2029
- Chart on Infectious disease - Market size and forecast 2024-2029 ($ billion)
- Data Table on Infectious disease - Market size and forecast 2024-2029 ($ billion)
- Chart on Infectious disease - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious disease - Year-over-year growth 2024-2029 (%)
- 10.5 Immunology - Market size and forecast 2024-2029
- Chart on Immunology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Immunology - Market size and forecast 2024-2029 ($ billion)
- Chart on Immunology - Year-over-year growth 2024-2029 (%)
- Data Table on Immunology - Year-over-year growth 2024-2029 (%)
- 10.6 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
- 10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.4.5 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.4.6 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.4.7 Russia - Market size and forecast 2024-2029
- Chart on Russia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.2 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.5.6 Thailand - Market size and forecast 2024-2029
- Chart on Thailand - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ billion)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- 12.5.7 Singapore - Market size and forecast 2024-2029
- Chart on Singapore - Market size and forecast 2024-2029 ($ billion)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ billion)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.6.2 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.3 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.4 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.6 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing research and development investments in biopharmaceuticals and personalized medicine
- Technological advancements in antibody engineering and production
- Growing demand for high-quality reagents in diagnostics and life sciences research
- 13.2 Market challenges
- High costs and long timelines associated with custom antibody development
- Stringent regulatory requirements and complex validation processes
- Technical complexities and high risk of project failure
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Rise of recombinant and engineered antibodies
- Integration of artificial intelligence and machine learning in antibody discovery
- Growing adoption of single B-cell screening technologies
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abcam plc
- Abcam plc - Overview
- Abcam plc - Product / Service
- Abcam plc - Key news
- Abcam plc - Key offerings
- SWOT
- 15.5 Abmart
- Abmart - Overview
- Abmart - Product / Service
- Abmart - Key offerings
- SWOT
- 15.6 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 BioLegend Inc.
- BioLegend Inc. - Overview
- BioLegend Inc. - Product / Service
- BioLegend Inc. - Key offerings
- SWOT
- 15.9 Cell Signaling Technology Inc.
- Cell Signaling Technology Inc. - Overview
- Cell Signaling Technology Inc. - Product / Service
- Cell Signaling Technology Inc. - Key offerings
- SWOT
- 15.10 Creative Diagnostics
- Creative Diagnostics - Overview
- Creative Diagnostics - Product / Service
- Creative Diagnostics - Key offerings
- SWOT
- 15.11 GenScript Biotech Corp.
- GenScript Biotech Corp. - Overview
- GenScript Biotech Corp. - Business segments
- GenScript Biotech Corp. - Key news
- GenScript Biotech Corp. - Key offerings
- GenScript Biotech Corp. - Segment focus
- SWOT
- 15.12 Kaneka Eurogentec SA
- Kaneka Eurogentec SA - Overview
- Kaneka Eurogentec SA - Product / Service
- Kaneka Eurogentec SA - Key offerings
- SWOT
- 15.13 Laboratory Corp.
- Laboratory Corp. - Overview
- Laboratory Corp. - Business segments
- Laboratory Corp. - Key news
- Laboratory Corp. - Key offerings
- Laboratory Corp. - Segment focus
- SWOT
- 15.14 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.15 ProMab Biotechnologies, Inc
- ProMab Biotechnologies, Inc - Overview
- ProMab Biotechnologies, Inc - Product / Service
- ProMab Biotechnologies, Inc - Key offerings
- SWOT
- 15.16 Rockland Immunochemicals Inc.
- Rockland Immunochemicals Inc. - Overview
- Rockland Immunochemicals Inc. - Product / Service
- Rockland Immunochemicals Inc. - Key offerings
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 YenZym Antibodies, LLC
- YenZym Antibodies, LLC - Overview
- YenZym Antibodies, LLC - Product / Service
- YenZym Antibodies, LLC - Key offerings
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
